✦ LIBER ✦

Pain outcomes in patients with advanced breast cancer and bone metastases : Results from a randomized, double-blind study of denosumab and zoledronic acid

✍ Scribed by Charles S. Cleeland; Jean-Jacques Body; Alison Stopeck; Roger von Moos; Lesley Fallowfield; Susan D. Mathias; Donald L. Patrick; Mark Clemons; Katia Tonkin; Norikazu Masuda; Allan Lipton; Richard de Boer; Stefania Salvagni; Celia Tosello Oliveira; Yi Qian; Qi Jiang; Roger Dansey; Ada Braun; Karen Chung

Book ID: 115554728
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 346 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27789

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a prospective, randomized, do

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

✍ Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Cost-Effectiveness of Denosumab Compared

Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases

✍ Jipan Xie; Melissa Diener; Rachael Sorg; Eric Q. Wu; Madhav Namjoshi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 544 KB

Denosumab versus zoledronic acid in pati

Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial

✍ J. Brown*; M. Carducci; K. Fizazi; M. Smith; R. Damião; L. Karsh; P. Milecki; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Results From a Phase 3 Randomized, Doubl

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PCN146 HEALTH RESOURCE UTILIZATION OF SU

PCN146 HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

✍ JJ Body; R von Moos; A Stopeck; Y Qian; A Braun 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Denosumab versus zoledronic acid for tre

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

✍ Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawr 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 840 KB